316 related articles for article (PubMed ID: 29753159)
21. Epidemiologic and microbiologic evaluation of catheter-line bloodstream infection in a pediatric hematopoietic stem cell transplant center.
Aksoy BA; Kara M; Sütçü M; Özbek A; Ersoy GZ; Öner ÖB; Aydoğdu S; Gül D; Bozkurt C; Fışgın T
Am J Infect Control; 2024 Jan; 52(1):81-86. PubMed ID: 37591312
[TBL] [Abstract][Full Text] [Related]
22. Utility of Electronic Medical Records to Assess the Relationship Between Parenteral Nutrition and Central Line-Associated Bloodstream Infections in Adult Hospitalized Patients.
Ippolito P; Larson EL; Furuya EY; Liu J; Seres DS
JPEN J Parenter Enteral Nutr; 2015 Nov; 39(8):929-34. PubMed ID: 24898208
[TBL] [Abstract][Full Text] [Related]
23. The bundle "plus": the effect of a multidisciplinary team approach to eradicate central line-associated bloodstream infections.
Walz JM; Ellison RT; Mack DA; Flaherty HM; McIlwaine JK; Whyte KG; Landry KE; Baker SP; Heard SO;
Anesth Analg; 2015 Apr; 120(4):868-76. PubMed ID: 24149581
[TBL] [Abstract][Full Text] [Related]
24. Pediatric Ambulatory Central Line-Associated Bloodstream Infections.
Rinke ML; Heo M; Saiman L; Bundy DG; Rosenberg RE; DeLaMora P; Rabin B; Zachariah P; Mirhaji P; Ford WJH; Obaro-Best O; Drasher M; Klein E; Peshansky A; Oyeku SO
Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33386333
[TBL] [Abstract][Full Text] [Related]
25. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report.
Rogers AE; Eisenman KM; Dolan SA; Belderson KM; Zauche JR; Tong S; Gralla J; Hilden JM; Wang M; Maloney KW; Dominguez SR
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27616655
[TBL] [Abstract][Full Text] [Related]
27. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.
Tedja R; Gordon SM; Fatica C; Fraser TG
Infect Control Hosp Epidemiol; 2014 Feb; 35(2):164-8. PubMed ID: 24442079
[TBL] [Abstract][Full Text] [Related]
28. Multimodal interventions for bundle implementation to decrease central line-associated bloodstream infections in adult intensive care units in a teaching hospital in Taiwan, 2009-2013.
Lin WP; Chang YC; Wu UI; Hung MC; Chuang PY; Wang JT; Sheng WH; Chen YC; Chang SC
J Microbiol Immunol Infect; 2018 Oct; 51(5):644-651. PubMed ID: 28888825
[TBL] [Abstract][Full Text] [Related]
29. Hospital-acquired Staphylococcus aureus primary bloodstream infection: A comparison of events that do and do not meet the central line-associated bloodstream infection definition.
Kovacs CS; Fatica C; Butler R; Gordon SM; Fraser TG
Am J Infect Control; 2016 Nov; 44(11):1252-1255. PubMed ID: 27158091
[TBL] [Abstract][Full Text] [Related]
30. Rate and time to develop first central line-associated bloodstream infections when comparing open and closed infusion containers in a Brazilian Hospital.
Vilins M; Blecher S; Silva MA; Rosenthal VD; Barker K; Salomao R
Braz J Infect Dis; 2009 Oct; 13(5):335-40. PubMed ID: 20428631
[TBL] [Abstract][Full Text] [Related]
31. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
[TBL] [Abstract][Full Text] [Related]
32. Impact of switching from an open to a closed infusion system on rates of central line-associated bloodstream infection: a meta-analysis of time-sequence cohort studies in 4 countries.
Maki DG; Rosenthal VD; Salomao R; Franzetti F; Rangel-Frausto MS
Infect Control Hosp Epidemiol; 2011 Jan; 32(1):50-8. PubMed ID: 21121815
[TBL] [Abstract][Full Text] [Related]
33. Implementation of central venous catheter bundle in an intensive care unit in Kuwait: Effect on central line-associated bloodstream infections.
Salama MF; Jamal W; Al Mousa H; Rotimi V
J Infect Public Health; 2016; 9(1):34-41. PubMed ID: 26138518
[TBL] [Abstract][Full Text] [Related]
34. Ambulatory pediatric oncology CLABSIs: epidemiology and risk factors.
Rinke ML; Milstone AM; Chen AR; Mirski K; Bundy DG; Colantuoni E; Pehar M; Herpst C; Miller MR
Pediatr Blood Cancer; 2013 Nov; 60(11):1882-9. PubMed ID: 23881643
[TBL] [Abstract][Full Text] [Related]
35. The incidence, aetiology and antimicrobial susceptibility of central line-associated bloodstream infections in intensive care unit patients at a private tertiary care hospital in Mumbai, India.
Singhal T; Shah S; Thakkar P; Naik R
Indian J Med Microbiol; 2019; 37(4):521-526. PubMed ID: 32436874
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for central line-associated bloodstream infection in pediatric intensive care units.
Wylie MC; Graham DA; Potter-Bynoe G; Kleinman ME; Randolph AG; Costello JM; Sandora TJ
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1049-56. PubMed ID: 20731595
[TBL] [Abstract][Full Text] [Related]
37. Central line-associated bloodstream infections in limited-resource countries: a review of the literature.
Rosenthal VD
Clin Infect Dis; 2009 Dec; 49(12):1899-907. PubMed ID: 19911941
[TBL] [Abstract][Full Text] [Related]
38. Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.
Mikulska M; Raiola AM; Galaverna F; Balletto E; Borghesi ML; Varaldo R; Gualandi F; Giannoni L; Pastori G; Giacobbe DR; Signori A; Del Bono V; Viscoli C; Bacigalupo A; Angelucci E
Biol Blood Marrow Transplant; 2018 Jan; 24(1):109-118. PubMed ID: 28860000
[TBL] [Abstract][Full Text] [Related]
39. Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
Ziegler M; Landsburg D; Pegues D; Bilker W; Gilmar C; Kucharczuk C; Gorman T; Bink K; Moore A; Fitzpatrick R; Stadtmauer EA; Mangan P; Kraus K; Han JH
Biol Blood Marrow Transplant; 2019 May; 25(5):1004-1010. PubMed ID: 30481595
[TBL] [Abstract][Full Text] [Related]
40. Analysis of central line-associated bloodstream infections in the intensive care unit after implementation of central line bundles.
Shuman EK; Washer LL; Arndt JL; Zalewski CA; Hyzy RC; Napolitano LM; Chenoweth CE
Infect Control Hosp Epidemiol; 2010 May; 31(5):551-3. PubMed ID: 20334506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
